The NETRF Board of Scientific Advisors (BOSA), Board of Directors, and staff wish to thank Dr. Ramesh Shivdasani for his incredible leadership as BOSA Co- Chair from the panel’s founding in 2007 to 2016. His leadership has been instrumental in the development of NETRF’s now proven grant making process and the expansion of neuroendocrine tumor research world-wide, through NETRF funding. Under his leadership, NETRF has emerged as a prestigious and impactful funder of neuroendocrine tumor research attracting research proposals from top scientists and funding projects that have made significant advances in our understanding of neuroendocrine tumors. The Foundation is grateful for his dedication through his many years of service.
Dr. Joe Li, Vice Chair of the Board of Directors, recognizes Dr. Shivdasani for his service and compassion. “Ramesh is remarkably adept at explaining complicated science in a way that anyone could understand. But perhaps his greatest contribution is his kindness in supporting us as patients, family and friends who are living with this disease.”
Dr. George Fisher, Co-Chair of the BOSA, says it has been an honor to serve with Dr. Shivdasani.
Dr. Shivdasani’s research focuses on normal mechanisms of development and cell differentiation in the gastrointestinal tract and new targets for treatment of intestinal tumors. In 1996, he joined the staff of Dana-Farber and Brigham and Women’s Hospital, where he is a medical oncologist and laboratory investigator in the Gastrointestinal Cancer Center. Dr. Shivdasani received his medical and graduate degrees from The University of Michigan in 1989. He completed his residency in Internal Medicine at Brigham and Women’s Hospital, his fellowship in Medical Oncology at the Dana-Farber Cancer Institute, and post-doctoral research training at The Howard Hughes Medical Institute and Children’s Hospital Boston.
While Dr. Shivdasani has ended his term as BOSA co-chair, the Foundation is fortunate that he will remain as a member of the BOSA. Dr. Dan Chung, Clinical Chief of the Gastrointestinal Unit at Massachusetts General Hospital, will be the new co-chair, serving with co-chair Dr. George Fisher.